Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study

True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study

(2015) H Tiller et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial

(2015) Noortje P. Paridaans et al.   FETAL DIAGNOSIS AND THERAPY

Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage

(2015) Issaka Yougbaré et al.   JOURNAL OF CLINICAL INVESTIGATION

Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

(2012) Erwin W. Gelfand   NEW ENGLAND JOURNAL OF MEDICINE

The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources

(2011) Marian Knight et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fetal and Neonatal Alloimmune Thrombocytopenia

(2011) Luis D. Pacheco et al.   OBSTETRICS AND GYNECOLOGY

Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review

(2010) MM Kamphuis et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY